drugset / Trial / NCT02033512
TRANSDERMAL HRT RELIEVING POSTMENOPAUSAL SYMPTOMS
NaSingle-groupOpen-labelTreatment
Summary
There is a dilemma and a permanent debate about side effects on drugs administered orally. The first-pass metabolism is related with many side effects, since the metabolites of these compounds affect the course of human physiology. Conventional hormone therapy by oral route has been used for relieving menopausal symptoms. Transdermal estrogens have not been used extensively in Brazilian women with menopausal symptomatology, however; recently a previous long term study has indicated no increased risk breast cancer or vasomotor disorders in menopausal women, using transdermal HRT.
Timeline
- Start
- 2003-01
- Primary completion
- 2004-01
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Estradiol | Other / unclassified | 0.25 % | — |
| Subject | Estriol | Unknown | 0.1 % | Other |
| Subject | Progesterone | Other / unclassified | 10 % | — |
Indications
No indication recorded.